Association with nitric oxide synthase expression, p53 alteration and TGF β signal-transduction abnormality in human tumors
Association with nitric oxide synthase expression, p53 alteration and TGF β signal-transduction abnormality in human tumors
批准号:
12670164
负责人:
FURIHATA Mutsuo
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nitric oxide (NO) is free radical gas which is associated with several events in cell biology, including angiogenesis, neural transmission and cytotoxicity. Frequent iNOS expressions have been observed in many types of carcinomas. Immunoreactivity of iNOS has also suggested that iNOS might play an important role in the behavior of tumors. We immunohistochemically examined the expression of iNOS in patients with urothelial cancer, esophageal cancer, lung cancer and renal cancer to determine the significance for the tumor behavior. No urothelial cancers exhibited negative iNOS immunostaining were found. Of 105 tumors, fifty-five esophageal cancers were positive with anti-iNOS antibody. Positive immunoreaction of iNOS was also found more than 80% of lung cancers. No significant association between iNOS immunoreactivity and any clinicopathological factors as well as p53 immunoreactivity were found in each human cancer examined.It is accepted that mutation of the p53 gene plays a critical r … More ole in the process of the carcinogenesis of human cancer. Small numbers of in vivo studies have revealed that there was strong positive relationship between p53 gene mutation and the presence of iNOS in human malinancy, suggesting that an excess of endogenously formed NO directly generates a p53 gene mutation. We present here that there was significant relationship between p53 alterations not in urothelial cancers but in esophageal cancers.Genomic DNA from the RCC patients was examined by VHL gene analysis to characterize the genotype of alterations and their frequency of involvement in iNOS or p53 expression. Of 17 RCCs with VLH mutations, fifteen tumors (88.3%) exhibited cytoplasmic immunostaining, including five homogenous and ten heterogeneous. Of 9 RCCs without VHL mutations, four tumors (44.4%) exhibited cytoplasmic immunostaining, including two homogenous and two heterogeneous. No association between p53 overexpression and iNOS immunoreactivity or VHL alteration in RCCs examined were found. These findings provide evidence for frequent iNOS protein expression in RCCs with VHL mutations. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Furihata M. et al.: "p53 Mutation Arising in Arg72 Allele in the Tumorigenesis and Development of Carcinoma of the Urinary Tract"Clinical Cancer Research. 8. 1192-1195 (2002)
Furihata M.等人:“泌尿道癌的肿瘤发生和发展中Arg72等位基因中出现的p53突变”临床癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Liang SB, Furihata M. et al.: "Reduced hMSH2 protein expression in the development of precancerous skin lesions to squamous cell carcinoma"Virchows Archiv. 439. 622-627 (2001)
Liang SB、Furihata M. 等人:“在癌前皮肤病变发展为鳞状细胞癌过程中 hMSH2 蛋白表达降低”Virchows Archiv。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamanouchi H,Furihata M, et al: "Expression of cyclinE and cyclinD1 in non-small cell lung cancers"Lung Cancer. 31. 3-8 (2001)
Yamanouchi H、Furihata M 等人:“非小细胞肺癌中细胞周期蛋白 E 和细胞周期蛋白 D1 的表达”肺癌。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Furihata M et al.: "Genetic analysis of hMLH1 in transitional cell carcinoma of the urinary tract : promoter methylation or mutation"Journal of Urology. 165. 1760-1764 (2001)
Furihata M 等人:“尿路移行细胞癌中 hMLH1 的基因分析:启动子甲基化或突变”泌尿学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Molecular and immunohistochemical analysis of the PODXL and ITGB1 overexpression in pancreatic cancer preoperatively obtained by endoscopic ultrasound-guided fine needle aspiration
-
批准号:19K07461
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:FURIHATA Mutsuo
-
依托单位:
Molecular and immunohistochemical analysis of BART expression controlling the inhibition to pancreatic cancer invasion and metastasis
-
批准号:15K08346
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2015
-
负责人:FURIHATA Mutsuo
-
依托单位:
Genomic loci analysis associated with prostate cancer susceptibility using a genome-wide association study for the pathological diagnosis
-
批准号:24590412
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2012
-
负责人:FURIHATA Mutsuo
-
依托单位:
The analysis of the specific gene expression for castration-resistant prostate cancer in relation to the diagnostic and therapeutic application
-
批准号:21590372
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:FURIHATA Mutsuo
-
依托单位:
Genetic analysis of hormone-refractory prostate cancer in relation to the pathological diagnosis
-
批准号:18590331
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.72万
-
财政年份:2006
-
负责人:FURIHATA Mutsuo
-
依托单位:
Tumor-associated gene expression and DNA mismatch repair abnormality in human malignancy
-
批准号:09670190
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1997
-
负责人:FURIHATA Mutsuo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
-
批准号:2026JJ81586
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈燕华
-
依托单位:
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
-
批准号:2026JJ82384
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜志鹏
-
依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究
-
批准号:JCZRLH202601033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
-
批准号:2026JJ80394
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛琛
-
依托单位:
中性粒细胞弹性蛋白酶抑制剂Sivelestat通过CCN2/P53/BNIP3通路改善阿霉素心脏毒性线粒体自噬的分子机制研究
-
批准号:2026JJ30190
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小平
-
依托单位:
基于“心理应激”从P53/AMPK通路介导线粒体能量代谢研究疏肝健脾解毒方对肝郁型三阴乳腺癌铁死亡作用机制
-
批准号:2026JJ50614
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李琳霈
-
依托单位:
基于miR-218-5p/NDRG4/p53通路研究“阴中隐阳”手法针刺风池 穴治疗青光眼性视神经损伤的作用机制
-
批准号:JCZRLH202600426
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GINS1通过调控肿瘤干性及PTP4A1/p53信号轴促进非小细胞肺癌发生发展及靶向干预研究
-
批准号:JCZRLH202600663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位: